Submucosal injection of dexamethasone for the control of post-operative sequelae after mandibular third molar surgery

Objectives: To evaluate the efficacy of submucosal injection of 4mg/ml dexamethasone in comparison with normal saline (N/S) on mean post-operative pain, trismus, and swelling following mandibular third molar surgery. Methodology: This randomized controlled trial was conducted at the Department of Oral and Maxillofacial Surgery, Pakistan Atomic Energy Commission General Hospital Islamabad, over a period of 1 year from October 2024 to September 2025. There were 70 patients in our study, who were divided into two equal groups of 35 patients each. Group A received 1 ml dexamethasone (4 mg/ml) by submucosal injection, and Group B received 1 ml normal saline (N/S) by the same route. Individuals of either gender aged 18–45 years who had an impacted mandibular third molar were included. Patients with known corticosteroid allergies, pericoronitis, uncontrolled comorbidities, pregnant or nursing women were excluded. To create an aseptic environment, patients were asked to rinse with 0.2% chlorhexidine mouthwash. Thirty minutes before the incision, a 3 ml syringe with a Luer lock 23G×1 thin wall needle was used to inject either 1 ml N/S or 4 mg/1 ml Dexamethasone submucosally in the posterior-buccal soft tissue of the tooth being extracted. VAS score, interincisal distance, distance between tragus to corner of the mouth, distance between angle of the mandible to lateral corner of the eye, distance between tragus to soft tissue pogonion, and the number of 500 mg tablets of paracetamol taken orally after surgery were recorded for the third and seventh postoperative day. Results: In comparison to the control group, the study group reported considerably decreased pain on the 3rd and 7th postoperative days. Furthermore, the dexamethasone group experienced a substantial decrease in mean post-operative trismus and swelling. Conclusion: Submucosal dexamethasone injection is a successful intervention for reducing post-operative pain, trismus and swelling after the surgical extraction of impacted mandibular third molars.

Authors

Institutions

Publication Details

Journal
Annals of PIMS-Shaheed Zulfiqar Ali Bhutto Medical University
Published
2026-11-21
DOI
https://doi.org/10.48036/wt53dz84
Primary Topic
Anesthesia and Pain Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Submucosal injection of dexamethasone for the control of post-operative sequelae after mandibular third molar surgery

Kanza Ateeque, Omar Arshad
Annals of PIMS-Shaheed Zulfiqar Ali Bhutto Medical University
Anesthesia and Pain Management
article

Submucosal injection of dexamethasone for the control of post-operative sequelae after mandibular third molar surgery

Kanza Ateeque, Omar Arshad
article en

Abstract

Objectives: To evaluate the efficacy of submucosal injection of 4mg/ml dexamethasone in comparison with normal saline (N/S) on mean post-operative pain, trismus, and swelling following mandibular third molar surgery. Methodology: This randomized controlled trial was conducted at the Department of Oral and Maxillofacial Surgery, Pakistan Atomic Energy Commission General Hospital Islamabad, over a period of 1 year from October 2024 to September 2025. There were 70 patients in our study, who were divided into two equal groups of 35 patients each. Group A received 1 ml dexamethasone (4 mg/ml) by submucosal injection, and Group B received 1 ml normal saline (N/S) by the same route. Individuals of either gender aged 18–45 years who had an impacted mandibular third molar were included. Patients with known corticosteroid allergies, pericoronitis, uncontrolled comorbidities, pregnant or nursing women were excluded. To create an aseptic environment, patients were asked to rinse with 0.2% chlorhexidine mouthwash. Thirty minutes before the incision, a 3 ml syringe with a Luer lock 23G×1 thin wall needle was used to inject either 1 ml N/S or 4 mg/1 ml Dexamethasone submucosally in the posterior-buccal soft tissue of the tooth being extracted. VAS score, interincisal distance, distance between tragus to corner of the mouth, distance between angle of the mandible to lateral corner of the eye, distance between tragus to soft tissue pogonion, and the number of 500 mg tablets of paracetamol taken orally after surgery were recorded for the third and seventh postoperative day. Results: In comparison to the control group, the study group reported considerably decreased pain on the 3rd and 7th postoperative days. Furthermore, the dexamethasone group experienced a substantial decrease in mean post-operative trismus and swelling. Conclusion: Submucosal dexamethasone injection is a successful intervention for reducing post-operative pain, trismus and swelling after the surgical extraction of impacted mandibular third molars.

Annals of PIMS-Shaheed Zulfiqar Ali Bhutto Medical UniversityVol. 22(5)
Pakistan Atomic Energy Commission (PK)
Anesthesia and Pain Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Submucosal injection of dexamethasone for the control of post-operative sequelae after mandibular third molar surgery — Kanza Ateeque, Omar Arshad · Annals of PIMS-Shaheed Zulfiqar Ali Bhutto Medical University (2026) | TGRS Research Map | TGRS